Search

Your search keyword '"Diagnostic reagents industry -- Securities"' showing total 138 results
Start Over Descriptor "Diagnostic reagents industry -- Securities" Topic news, opinion and commentary
138 results on '"Diagnostic reagents industry -- Securities"'

1. Moody's Ratings affirms Revvity's Baa3 senior unsecured ratings; outlook stable

Subjects
Revvity Inc. -- Securities, Moody's Investors Service Inc. -- Securities, Diagnostic reagents industry -- Securities, Company securities, General interest, News, opinion and commentary
Abstract

New York City: Moody's Investors Service has issued the following news release: Moody's Ratings (Moody's) affirmed the Baa3 senior unsecured ratings of Revvity, Inc. ('Revvity'). The outlook remains stable. The [...]

Published
2024

2. Investing in Undervalued Mid-Cap Stocks Amid Growing Rate Uncertainty

Subjects
Quidel Corp. -- Securities, Euronet Worldwide Inc. -- Securities, Financial analysts, Stocks, Data processing services -- Securities, Diagnostic reagents industry -- Securities, Company securities, General interest, News, opinion and commentary
Abstract

* Mid-cap stocks offer a balance of growth potential and stability between small and large caps. * Euronet Worldwide and Quidel Corporation are strong mid-cap companies with different growth paths. [...]

Published
2024

3. Quidel Announces Private Exchange Transactions

Subjects
Quidel Corp. -- Securities, Stock offerings, Diagnostic reagents industry -- Securities, Securities offerings, Company securities, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Quidel Corporation has issued the following press release: Quidel Corporation (NASDAQ: QDEL) ('Quidel'), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced [...]

Published
2019

4. Moody's announces completion of a periodic review of ratings of Lantheus Medical Imaging, Inc

Subjects
Moody's Investors Service Inc. -- Securities, Lantheus Medical Imaging Inc. -- Securities, Diagnostic reagents industry -- Securities, Medical imaging equipment -- Evaluation, Company securities, General interest, News, opinion and commentary
Abstract

New York City: Moody's Investors Service has issued the following press release:Moody's Investors Service ('Moody's') has completed a periodic review of the ratings of Lantheus Medical Imaging, Inc and other [...]

Published
2019

5. FORM 8-K: QUIDEL CORP|DE Files Current Report Updated on 01-06-18

Subjects
Quidel Corp. -- Securities, Stock offerings, Diagnostic reagents industry -- Securities, State laws, Company securities, General interest, News, opinion and commentary
Abstract

Washington: QUIDEL CORP /DE , has filed FORM 8-K (Current Report) with Securities and Exchange Commission on June 01, 2018 Item 3.02 UREGISTERED SALES OF EQUITY SECURITIES On May 31, [...]

Published
2018

6. Quidel Announces Private Exchange Transactions (Updated on 31 May 2018)

Subjects
Quidel Corp. -- Securities, Stock offerings, Diagnostic reagents industry -- Securities, Company securities, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Quidel Corporation has issued the following press release: Quidel Corporation (NASDAQ: QDEL) ('Quidel'), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced [...]

Published
2018

7. Quidel Announces Private Exchange Transactions

Subjects
Quidel Corp. -- Securities, Stock offerings, Diagnostic reagents industry -- Securities, Company securities, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Quidel Corporation has issued the following press release: Quidel Corporation (NASDAQ: QDEL) ('Quidel'), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced [...]

Published
2018

8. Profile of Julian Baines, Chief Executive Officer of EKF Diagnostics

Subjects
Alere Inc. -- Securities, Chief executive officers, Diagnostic reagents industry -- Securities, Company securities, General interest, News, opinion and commentary
Abstract

Dublin: Following is the Profile of Julian Baines, Chief Executive Officer of EKF Diagnostics: Julian was Group CEO of BBI where he undertook a management buyout in 2000, a flotation [...]

Published
2018

9. Profile of Julian Baines, Chief Executive Officer of EKF Diagnostics

Subjects
Alere Inc. -- Securities, Chief executive officers, Diagnostic reagents industry -- Securities, Company securities, General interest, News, opinion and commentary
Abstract

Dublin: Following is the Profile of Julian Baines, Chief Executive Officer of EKF Diagnostics: Julian was Group CEO of BBI where he undertook a management buyout in 2000, a flotation [...]

Published
2018

10. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
United States. Securities and Exchange Commission, Alere Inc. -- Securities, Abbott Laboratories (Abbott Park, Illinois) -- Securities, Diagnostic reagents industry -- Securities, Capital stock, Preferred stocks, Pharmaceutical industry -- Securities, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., Sept. 18, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B [...]

Published
2017

11. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, Preferred stocks, Company securities, Company dividends, General interest, News, opinion and commentary
Abstract

WALTHAM: Alere Inc has issued the following press release: Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its [...]

Published
2017

12. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, Preferred stocks, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., June 23, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B [...]

Published
2017

13. Profile of George Migausky Executive Vice President and Chief Financial Officer of Dimension Therapeutics

Subjects
IGEN International Inc. -- Securities, Diagnostic reagents industry -- Securities, Initial public offerings, Chief financial officers, Company public offering, Company securities, General interest, News, opinion and commentary
Abstract

Woburn, MA: Following is the Profile of George Migausky Executive Vice President and Chief Financial Officer of Dimension Therapeutics: George Migausky has served as Executive Vice President and Chief Financial [...]

Published
2017

14. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, Preferred stocks, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., March 20, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B [...]

Published
2017

15. Profile of George Migausky Executive Vice President of Dimension Therapeutics, Inc

Subjects
IGEN International Inc. -- Securities, Vice presidents (Organizations), Diagnostic reagents industry -- Securities, Initial public offerings, Chief financial officers, Company public offering, Company securities, General interest, News, opinion and commentary
Abstract

Massachusetts: Following is the Profile of George Migausky Executive Vice President of Dimension Therapeutics, Inc: George Migausky has served as Executive Vice President and Chief Financial Officer (CFO) since joining [...]

Published
2017

16. Profile of Julian Baines Chief Executive Officer of EKF DIAGNOSTICS HOLDINGS PLC

Subjects
Alere Inc. -- Securities, Chief executive officers, Diagnostic reagents industry -- Securities, Company securities, General interest, News, opinion and commentary
Abstract

London: Following is the Profile of Julian Baines Chief Executive Officer of EKF DIAGNOSTICS HOLDINGS PLC: Julian was Group CEO of BBI where he undertook a management buyout in 2000, [...]

Published
2017

17. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, Preferred stocks, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., Dec. 16, 2016 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B [...]

Published
2016

18. Moody's expectations for Abbott's ratings unchanged following news of medical optics sale

Subjects
Johnson & Johnson -- Securities, Alere Inc. -- Securities, Abbott Laboratories (Abbott Park, Illinois) -- Securities, St. Jude Medical Inc. -- Securities, Moody's Investors Service Inc. -- Securities, Diagnostic reagents industry -- Securities, Medical equipment industry -- Securities, Financial services -- Evaluation -- Securities, Pharmaceutical industry -- Securities, Company securities, Financial services industry, General interest, News, opinion and commentary
Abstract

New York: Moody's Investors Service has issued the following news release: Moody's Investors Service, ('Moody's') said that the rating agency continues to expect that Abbott's senior unsecured ratings will be [...]

Published
2016

19. Moody's: Lantheus' equity issuance is credit positive; ratings unaffected

Subjects
Avista Capital Holdings L.P. -- Securities, Moody's Investors Service Inc. -- Securities, Lantheus Medical Imaging Inc. -- Securities, Investment companies -- Evaluation -- Securities, Diagnostic reagents industry -- Securities, Medical imaging equipment -- Evaluation, Company securities, General interest, News, opinion and commentary
Abstract

New York: Moody's Investors Service has issued the following news release: Moody's Investors Service ('Moody's') commented that Lantheus Medical Imaging, Inc.'s ('Lantheus') equity issuance is credit positive. There is no [...]

Published
2016

20. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, Preferred stocks, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., Sept. 14, 2016 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B [...]

Published
2016

21. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, Preferred stocks, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., June 2, 2016 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B [...]

Published
2016

22. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, Preferred stocks, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., Dec. 15, 2015 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series [...]

Published
2015

23. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, Preferred stocks, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., Sept. 1, 2015 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series [...]

Published
2015

24. Sigma-Aldrich Corporation Declares Quarterly Dividend

Subjects
Merck KGaA -- Securities, Sigma-Aldrich Corp. -- Securities, Diagnostic reagents industry -- Securities, Dividends, Pharmaceutical industry -- Securities, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

ST. LOUIS, Aug. 24, 2015 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company (the 'Company'), announces a quarterly cash dividend of $0.23 per share. On [...]

Published
2015

25. Lantheus Holdings, Inc. Prices Its Initial Public Offering

Subjects
Lantheus Medical Imaging Inc. -- Securities, Diagnostic reagents industry -- Securities, Medical imaging equipment, Initial public offerings, Company public offering, Company securities, Business, Business, international, News, opinion and commentary
Abstract

Byline: NORTH BILLERICA, MA, Jun 24, 2015 (Marketwired via COMTEX) -- Lantheus Holdings, Inc. ('Lantheus Holdings' or the 'Company'), the parent company of Lantheus Medical Imaging, Inc. ('LMI'), a global [...]

Published
2015

26. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
PR Newswire Association L.L.C. -- Securities, Alere Inc. -- Securities, Dividends, Diagnostic reagents industry -- Securities, News agencies -- Securities, Preferred stocks, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

[[para]]WALTHAM, Mass., June 1, 2015 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series [...]

Published
2015

27. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Subjects
PR Newswire Association L.L.C. -- Securities, Alere Inc. -- Securities, News agencies -- Securities, Diagnostic reagents industry -- Securities, Capital stock, Preferred stocks, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., Dec. 10, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series [...]

Published
2014

28. Third Quarter Results, Technical Update, Quarterly Dividend, and Protein Supplement Launch - Research Reports on Newfield, Canadian Natural, Baker Hughes, Sigma-Aldrich and Mosaic

Subjects
Newfield Exploration Co. -- Securities, Baker Hughes Inc. -- Securities, Sigma-Aldrich Corp. -- Securities, Petroleum services industry -- Securities, Diagnostic reagents industry -- Securities, Oil and gas field equipment industry -- Securities, Company securities, Business, News, opinion and commentary
Abstract

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, November 3, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Newfield Exploration Co. [...]

Published
2014

29. Alere Inc. Declares Cash Dividend on Its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Diagnostic reagents industry -- Securities, Capital stock, Preferred stocks, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., Sept. 2, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today has declared a cash dividend of $3.00 per [...]

Published
2014

30. Sigma-Aldrich Announces Q2 2014 Earnings Conference Call and Cash Dividend

Subjects
Sigma-Aldrich Corp. -- Securities, Diagnostic reagents industry -- Securities, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

ST. LOUIS, July 9, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company, will hold its quarterly conference call to discuss second quarter 2014 financial [...]

Published
2014

31. Lantheus Holdings, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering

Subjects
United States. Securities and Exchange Commission, Wells Fargo & Co. -- Securities, Lantheus Medical Imaging Inc. -- Securities, Going public (Securities), Diagnostic reagents industry -- Securities, Medical imaging equipment, Company public offering, Company securities, Business, Business, international, News, opinion and commentary
Abstract

Byline: NO. BILLERICA, MA, Jun 24, 2014 (Marketwired via COMTEX) -- Lantheus Holdings, Inc. ('Lantheus Holdings' or the 'Company'), the parent company of Lantheus Medical Imaging, Inc. ('LMI'), a global [...]

Published
2014

32. Alere Opts Not to Pursue Initial Public Offering by BBI Diagnostics Group plc

Subjects
Alere Inc. -- Securities, Going public (Securities), Diagnostic reagents industry -- Securities, Company public offering, Company securities, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., June 18, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced that it has elected not to proceed at this time with its previously announced plans to pursue [...]

Published
2014

33. Quarterly Dividends, Divestures, Commercial Facility Expansions, and Notes Offer Pricing - Analyst Notes on ConocoPhillips, Hess, Energy Transfer, Sigma-Aldrich and Rosetta Resources

Subjects
Energy Transfer L.P. -- Securities, Sigma-Aldrich Corp. -- Securities, ConocoPhillips Co. -- Securities, Hess Corp. -- Securities, Gas transmission industry -- Securities, Petroleum industry -- Securities, Petroleum services industry -- Securities, Diagnostic reagents industry -- Securities, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, May 29, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding ConocoPhillips (NYSE: COP), [...]

Published
2014

34. Earnings Results Release, Quarterly Dividends, and Introduction of New Products - Analyst Notes on Rockwood, Sigma-Aldrich, IFF, Valspar and Platform

Subjects
Valspar Corp. -- Securities, International Flavors & Fragrances Inc. -- Securities, Rockwood Holdings Inc. -- Securities, Sigma-Aldrich Corp. -- Securities, Essences and essential oils industry -- Securities, Specialty chemicals industry -- Securities, Paint industry -- Securities, Diagnostic reagents industry -- Securities, Company securities, Business, News, opinion and commentary
Abstract

Editor Note: For more information about this release, please scroll to bottom NEW YORK, May 20, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Rockwood Holdings, Inc. [...]

Published
2014

35. Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Diagnostic reagents industry -- Securities, Capital stock, Preferred stocks, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., May 15, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative diagnostics [...]

Published
2014

36. Sigma-Aldrich Corporation Declares Quarterly Dividend

Subjects
Sigma-Aldrich Corp. -- Securities, Diagnostic reagents industry -- Securities, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

ST. LOUIS, May 6, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company (the 'Company'), announces a quarterly cash dividend of $0.23 per common share. [...]

Published
2014

37. Reported and Upcoming Financial Results, and Dividends - Analyst Notes on Cloud Peak Energy, Rockwood, Denbury, Sigma-Aldrich and Alliance Resource Partners

Subjects
Alliance Resource Partners L.P. -- Securities, Denbury Resources Inc. -- Securities, Sigma-Aldrich Corp. -- Securities, Coal industry -- Securities, Gas industry -- Securities, Diagnostic reagents industry -- Securities, Company securities, Business, News, opinion and commentary
Abstract

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, May 2, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Cloud Peak Energy [...]

Published
2014

38. Healthcare Companies Report Acquisitions, Upcoming Results Schedules, Dividends, and Annual Reviews - Analyst Notes on Pfizer, Magellan Health Services, Prothena, Alere, and KYTHERA

Subjects
Magellan Health Services Inc. -- Securities, Pfizer Inc. -- Securities, Alere Inc. -- Securities, Health care industry -- Securities, Diagnostic reagents industry -- Securities, Pharmaceutical industry -- Securities, Health care industry, Company securities, Business, News, opinion and commentary
Abstract

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, March 21, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Pfizer Inc. (NYSE: [...]

Published
2014

39. Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Diagnostic reagents industry -- Securities, Capital stock, Preferred stocks, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., March 3, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR ), a global leader in empowering individuals to take greater control of their health at home by connecting innovative [...]

Published
2014

40. Microsoft, ImClone post gains

Author

Talley, Karen

Subjects
Microsoft Corp. -- Company sales and earnings, Microsoft Corp. -- Securities, ImClone Systems Inc. -- Company sales and earnings, ImClone Systems Inc. -- Securities, Stock price indexes -- Forecasts and trends, Computer software industry -- Company sales and earnings, Computer software industry -- Securities, Diagnostic reagents industry -- Company sales and earnings, Diagnostic reagents industry -- Securities, Stocks -- Prices and rates, Stocks -- Forecasts and trends, Market trend/market analysis, Company earnings/profit, Company securities, News, opinion and commentary
Published
2007

41. Sigma-Aldrich Corporation Declares Increased Quarterly Dividend

Subjects
Sigma-Aldrich Corp. -- Securities, Diagnostic reagents industry -- Securities, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

ST. LOUIS, Feb. 11, 2014 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company (the 'Company'), announced an increase of 7% in its quarterly cash [...]

Published
2014

42. Sell rating on ImClone are few; Janney Montgomery sets low price target on stock; focus on deferred revenue

Author

Nasaw, Daniel

Subjects
ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Evaluation, ImClone Systems Inc. -- Economic aspects, Janney Montgomery Scott -- Officials and employees, Stocks -- Prices and rates, Stocks -- Evaluation, Investment analysis -- Reports, Financial analysts -- Beliefs, opinions and attitudes, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Evaluation, Diagnostic reagents industry -- Economic aspects, Company pricing policy, Company securities, News, opinion and commentary
Published
2004

43. Icahn trims his holdings in ImClone

Author

Windham, Christopher

Subjects
ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Product development, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Product development, Company securities, News, opinion and commentary, Erbitux (Medication) -- Research
Published
2004

45. Aide Says Stewart Sold Stock on Tip; Witness recounts what he said were efforts by his ex-boss, Stewart's stockbroker, to get him to adopt 'cover stories

Author

Mulligan, Thomas S.

Subjects
Merrill Lynch & Company Inc. -- Officials and employees, ImClone Systems Inc. -- Securities, Diagnostic reagents industry -- Securities, Fraud -- Cases, Obstruction of justice -- Cases, Securities industry -- Officials and employees, Company legal issue, Company securities, Securities industry, General interest, News, opinion and commentary
Published
2004

47. Stewart Case Poses Challenges for All Parties as Trial Begins Today

Author

Mulligan, Thomas S.

Subjects
ImClone Systems Inc. -- Securities, Diagnostic reagents industry -- Securities, Obstruction of justice -- Cases, Securities fraud -- Cases, Company securities, Company legal issue, General interest, News, opinion and commentary
Published
2004

48. Alere Inc announces USD3.00 per preferred share dividend

Subjects
Alere Inc. -- Securities, Diagnostic reagents industry -- Securities, Dividends, Company securities, Company dividends, General interest, News, opinion and commentary
Abstract

Dec 12, 2013 (M2 EQUITYBITES via COMTEX) -- Health information company Alere Inc (NYSE:ALR) Wednesday declared a dividend of USD3.00 per share on its Series B convertible perpetual preferred stock [...]

Published
2013

49. Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

Subjects
Alere Inc. -- Securities, Diagnostic reagents industry -- Securities, Capital stock, Preferred stocks, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

WALTHAM, Mass., Dec. 11, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid [...]

Published
2013

50. Sigma-Aldrich Corporation Declares $0.215 Per Share Quarterly Dividend

Subjects
Sigma-Aldrich Corp. -- Securities, Diagnostic reagents industry -- Securities, Dividends, Company securities, Company dividends, Business, News, opinion and commentary
Abstract

ST. LOUIS, May 7, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company (the 'Company'), announced today at its 2013 Annual Shareholders Meeting that [...]

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results